J. Safra Asset Management’s Edwards Lifesciences EW Stock Holding History

J. Safra Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37K	Buy	462 +266	+136%	+$21.9K	﹤0.01%	274
2025 Q4	$16.7K	Buy	196 +186	+1,860%	+$15.3K	﹤0.01%	328
2025 Q3	$778	Buy	+10	New	+$781	﹤0.01%	456
2022 Q4	–	Sell	-11	Closed	–	–	87
2022 Q3	$0	Buy	+11	New	+$1.06K	﹤0.01%	57
2022 Q2	–	Sell	-14	Closed	–	–	69
2022 Q1	$0	Buy	+14	New	+$1.57K	﹤0.01%	78

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

J. Safra Asset Management's EW Position: Q1 2026 in Review

J. Safra Asset Management increased its Edwards Lifesciences (EW) stake by 136% in Q1 2026, buying an estimated $21.9K and bringing the position to 462 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #274.

J. Safra Asset Management first reported a position in EW in Q1 2022 and has held it in 5 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

J. Safra Asset Management held 462 shares of Edwards Lifesciences worth $37K as of Q1 2026.
J. Safra Asset Management bought 266 Edwards Lifesciences shares in Q1 2026, an estimated $21.9K.
Edwards Lifesciences made up ﹤0.01% of J. Safra Asset Management's portfolio in Q1 2026, its #274 holding.
J. Safra Asset Management first reported a position in Edwards Lifesciences in Q1 2022 and has held it in 5 quarters since.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on J. Safra Asset Management's 13F filing for Q1 2026, filed 4 May 2026.